TGF-β promotes colorectal cancer cell growth in vitro and in vivo

Hepato-Gastroenterology

Volumn 60, Issue 124, 2013, Pages 715-719

  Sun, Gang ^a   Cao, Dachun ^a   Sun, Zhixin ^b   Zhou, Kun ^a   Wang, Yu ^a   Liu, Hailin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Changning Center Hospital   (China)

Author keywords

Colorectal cancer; TGF ; Tumor growth

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COLORECTAL CANCER; DNA SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR PROMOTION; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84879569057     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12755     Document Type: Article

References (30)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2008. CA: a cancer journal for clinicians 2008; 58:71-96. (Pubitemid 351521864)
2. Grady WM, Myeroff LL, Swinler SE, et al.: Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res 1999; 59:320-324. (Pubitemid 29048861)
3. Yang X, Letterio JJ, Lechleider RJ, et al.: Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. The EMBO Journal 1999; 18:1280-1291. (Pubitemid 29110312)
4. Zhang Y, Musci T, Derynck R: The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function. Curr Biol 1997; 7:270-276. (Pubitemid 27176853)
5. Hayashida T, Decaestecker M, Schnaper HW: Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. FASEB J 2003; 17:1576-1578.
6. Becker C, Fantini MC, Schramm C, et al.: TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 2004; 21:491-501. (Pubitemid 39370505)
7. Derynck R, Akhurst RJ, Balmain A: TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001; 29:117-129. (Pubitemid 32952643)
8. Massagué J: A very private TGF-beta receptor embrace. Mol Cell 2008; 29:149-150.
9. Kang JS, Liu C, Derynck R: New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol 2009; 19:385-394.
10. Pardali E, ten Dijke P: Transforming growth factor-beta signaling and tumor angiogenesis. Front Biosci 2009; 14:4848-4861.
11. Massagué J: TGFbeta in Cancer. Cell 2008; 134:215-230.
12. Alazzouzi H, Alhopuro P, Salovaara R, et al.: SMAD4 as a prognostic marker in colorectal cancer. Clin Cancer Res 2005; 11:2606-2611. (Pubitemid 40569460)
13. Powell SM, Harper JC, Hamilton SR, et al.: Inactivation of Smad4 in gastric carcinomas. Cancer Res 1997; 57:4221-4224. (Pubitemid 27413428)
14. Fukuchi M, Masuda N, Miyazaki T, et al.: Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma. Cancer 2002; 95:737-743. (Pubitemid 34839664)
15. D'Inzeo S, Nicolussi A, Ricci A, et al.: Role of reduced expression of SMAD4 in papillary thyroid carcinoma. J Mol Endocrinol 2010; 45:229-244.
16. Zhang B, Halder SK, Kashikar ND, et al.: Antimetastatic role of Smad4 signaling in colorectal cancer. Gastroenterology 2010; 138:969-980:e961-963.
17. Lee JD, Hempel N, Lee NY, Blobe GC: The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling. Carcinogenesis 2010; 31:175-183.
18. Jones E, Pu H, Kyprianou N: Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression. Expert Opin Ther Targets 2009; 13:227-234.
19. Miyazono K: Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proceedings Jpn Acad Ser B Phys Biol Sci 2009; 85:314-323.
20. Bierie B, Moses HL: Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev 2010; 21:49-59.
21. Yang L, Huang J, Ren X, et al.: Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 2008; 13:23-35. (Pubitemid 350309741)
22. Derynck R, Goeddel DV, Ullrich A, et al.: Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 1987; 47:707-712. (Pubitemid 17027960)
23. Dickson RB, Kasid A, Huff KK, et al.: Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene. Proc Natl Acad Sci U S A 1987; 84:837-841. (Pubitemid 17033902)
24. Inman GJ: Switching TGFbeta from a tumor suppressor to a tumor promoter. Curr Opin Genet Dev 2011; 21:93-99.
25. Zhou S, Buckhaults P, Zawel L, et al.: Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells. Proc Natl Acad Sci U S A 1998; 95:2412-2416. (Pubitemid 28145955)
26. Schmitz KJ, Wohlschlaeger J, Lang H, et al.: Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol 2008; 48:83-90. (Pubitemid 350191996)
27. Chadha KS, Khoury T, Yu J, et al.: Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma. Ann Surg Oncol 2006; 13:933-939.
28. Handra-Luca A, Bilal H, Bertrand JC, et al.: Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation. Am J Path 2003; 163:957-967. (Pubitemid 37040131)
29. Lin CW, Hou WC, Shen SC, et al.: Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 2008; 29:1807-1815.
30. Vial E, Sahai E, Marshall CJ: ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for rumor cell motility. Cancer Cell 2003; 4:67-79. (Pubitemid 36904162) School